Additionally, Weinger et al. identified that levels of soluble MERTK were higher in chronic active MS lesions, whereas in chronic silent MS lesions, the level of soluble AXL was elevated compared to healthy controls [89]. The gene discussed is AXL; the disease is myeloid sarcoma.